Disruption of Bcl-2 and Bcl-xL by viral proteins as a possible cause of cancer

被引:18
作者
Alibek, Kenneth [1 ,2 ]
Irving, Stephanie [1 ]
Sautbayeva, Zarina [1 ]
Kakpenova, Ainur [1 ]
Bekmurzayeva, Aliya [1 ]
Baiken, Yeldar [1 ]
Imangali, Nurgul [3 ]
Shaimerdenova, Madina [3 ]
Mektepbayeva, Damel [1 ]
Balabiyev, Arnat [1 ]
Chinybayeva, Aizada [1 ]
机构
[1] Nazarbayev Univ, Nazarbayev Univ Res & Innovat Syst NURIS, Astana 010000, Kazakhstan
[2] Natl Med Holding, Astana 010000, Kazakhstan
[3] Nazarbayev Univ, Sch Sci & Technol, Astana 010000, Kazakhstan
关键词
Bcl-2; Bcl-xL; Herpesviruses; Human T-lymphotropic virus 1; Human papillomavirus; Hepatitis C virus; Apoptosis; Signaling pathways; Tumor suppressor genes; Cancer; EPSTEIN-BARR-VIRUS; SARCOMA-ASSOCIATED HERPESVIRUS; HUMAN-PAPILLOMAVIRUS TYPE-16; PROTEASOME-MEDIATED DEGRADATION; PRIMARY EFFUSION LYMPHOMA; GROWTH-FACTOR RECEPTOR; I TAX PROTEIN; KAPOSIS-SARCOMA; INHIBITS APOPTOSIS; HTLV-I;
D O I
10.1186/1750-9378-9-44
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Bcl proteins play a critical role in apoptosis, as mutations in family members interfere with normal programmed cell death. Such events can cause cell transformation, potentially leading to cancer. Recent discoveries indicate that some viral proteins interfere with Bcl proteins either directly or indirectly; however, these data have not been systematically described. Some viruses encode proteins that reprogramme host cellular signalling pathways controlling cell differentiation, proliferation, genomic integrity, cell death, and immune system recognition. This review analyses and summarises the existing data and discusses how viral proteins interfere with normal pro-and anti-apoptotic functions of Bcl-2 and Bcl-xL. Particularly, this article focuses on how viral proteins, such as Herpesviruses, HTLV-1, HPV and HCV, block apoptosis and how accumulation of such interference predisposes cancer development. Finally, we discuss possible ways to prevent and treat cancers using a combination of traditional therapies and antiviral preparations that are effective against these viruses.
引用
收藏
页数:13
相关论文
共 142 条
[1]  
Alenzi Faris Q, 2010, J Egypt Natl Canc Inst, V22, P87
[2]   Implication of human herpesviruses in oncogenesis through immune evasion and supression [J].
Alibek, Kenneth ;
Baiken, Yeldar ;
Kakpenova, Ainur ;
Mussabekova, Assel ;
Zhussupbekova, Samal ;
Akan, Madina ;
Sultankulov, Bolat .
INFECTIOUS AGENTS AND CANCER, 2014, 9
[3]  
Amundson SA, 2000, CANCER RES, V60, P6101
[4]   Insights into the mechanisms of CMV-mediated interference with cellular apoptosis [J].
Andoniou, CE ;
Degli-Esposti, MA .
IMMUNOLOGY AND CELL BIOLOGY, 2006, 84 (01) :99-106
[5]   Modulation of cell growth by the hepatitis C virus nonstructural protein NS5A [J].
Arima, N ;
Kao, CY ;
Licht, T ;
Padmanabhan, R ;
Sasaguri, Y ;
Padmanabhan, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) :12675-12684
[6]  
Azran I, 2004, RETROVIROLOGY, V1, P1
[7]   Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins [J].
Bellows, DS ;
Chau, BN ;
Lee, P ;
Lazebnik, Y ;
Burns, WH ;
Hardwick, JM .
JOURNAL OF VIROLOGY, 2000, 74 (11) :5024-5031
[8]   Epstein-Barr virus BALF1 is a BCL-2-like antagonist of the herpesvirus antiapoptotic BCL-2 proteins [J].
Bellows, DS ;
Howell, M ;
Pearson, C ;
Hazlewood, SA ;
Hardwick, JM .
JOURNAL OF VIROLOGY, 2002, 76 (05) :2469-2479
[9]   The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses [J].
Bernard, HU .
JOURNAL OF CLINICAL VIROLOGY, 2005, 32 :S1-S6
[10]   Antiviral drugs for cytomegalovirus diseases [J].
Biron, Karen K. .
ANTIVIRAL RESEARCH, 2006, 71 (2-3) :154-163